\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ total\\ contact\\ cast\\ for\\ several\\ months\\ with\\ frequent\\ cast\\ changes\\.\ \(0\)\
\-\ there\\ is\\ pes\\ planus\\ deformity\\.\\ there\\ is\\ subluxation\\ at\\ the\\ talonavicular\\ joint\\.\\ subluxation\\ is\\ also\\ noted\\ at\\ the\\ talocalcaneal\\,\\ calcaneocuboid\\ and\\ cubometatarsal\\ joints\\.\\ \ \(0\)\
\-\ there\\ is\\ severe\\ hallux\\ valgus\\ deformity\\ of\\ the\\ great\\ toe\\.\\ \ \(0\)\
\-\ a\\ freiberg\\ infraction\\ is\\ noted\\ at\\ the\\ head\\ of\\ the\\ second\\ metatarsal\\.\\ there\\ are\\ no\\ periosteal\\ reaction\\.\ \(0\)\
\-\ charcot\\ arthroapathy\\ of\\ the\\ foot\\ and\\ ankle\ \(0\)\
\-\ 1\\.\\ charcot\\‚\\Ä\\ôs\\ neuropathic\\ joint\\ \ \(0\)\
\-\ 2\\.\\ trauma\\ \ \(0\)\
\-\ 3\\.\\ congenital\\ \ \(0\)\
\-\ 4\\.\\ metabolic\ \(0\)\
\-\ 31\\ year\\-old\\ woman\\ with\\ a\\ history\\ of\\ uncontrolled\\ diabetes\\ and\\ prior\\ left\\ bka\\ presents\\ with\\ right\\ foot\\ and\\ ankle\\ pain\\.\\ she\\ reports\\ multiple\\ ulcers\\ of\\ her\\ right\\ foot\\ and\\ recurrent\\ foot\\ pain\\.\\ \\ prior\\ x\\-rays\\ have\\ noted\\ right\\ foot\\ deformity\\ and\\ osteomyelitis\\.\ \(0\)\
\-\ this\\ patient\\‚\\Ä\\ôs\\ history\\ of\\ poorly\\ controlled\\ diabetes\\,\\ prior\\ foot\\ ulcers\\,\\ foot\\ pain\\ and\\ lower\\ extremity\\ swelling\\ describes\\ a\\ clinical\\ picture\\ of\\ joint\\ neuropathy\\.\\ the\\ imaging\\ studies\\ from\\ today\\ and\\ prior\\ visits\\ have\\ noted\\ foot\\ deformities\\ without\\ healing\\.\\ more\\ so\\,\\ the\\ imaging\\ studies\\ and\\ clinical\\ symptoms\\ are\\ most\\ consistent\\ with\\ charcot\\‚\\Ä\\ôs\\ neuroarthropathy\\ of\\ the\\ foot\\ and\\ ankle\\.\\ \ \(0\)\
\-\ charcot\\ neuroarthoropahty\\ is\\ a\\ progressive\\,\\ noninfectious\\,\\ destructive\\ disease\\ of\\ the\\ bones\\ and\\ joints\\ in\\ persons\\ with\\ sensory\\ neuropathy\\.\\ the\\ disease\\ can\\ affect\\ any\\ joint\\,\\ but\\ most\\ commonly\\ seen\\ in\\ the\\ joints\\ of\\ the\\ foot\\ and\\ ankle\\.\\ causes\\ include\\ alcoholism\\,\\ leprosy\\,\\ tabes\\ dorsalis\\,\\ myelomenignocele\\ and\\ congenital\\ insensitivity\\ to\\ pain\\.\\ the\\ most\\ common\\ cause\\ in\\ developed\\ countries\\ is\\ diabetes\\.\\ patients\\ with\\ type\\ 1\\ diabetes\\ commonly\\ present\\ in\\ the\\ fifth\\ decade\\ after\\ an\\ average\\ duration\\ of\\ diabetes\\ of\\ 20\\-24\\ years\\.\\ where\\ as\\ type\\ 2\\ diabetic\\ patients\\ present\\ more\\ commonly\\ with\\ charcot\\ nueuropathy\\ \\ in\\ the\\ sixth\\ decade\\ after\\ 5\\-9\\ years\\ with\\ the\\ disease\\.\\ charcot\\ nueroarthorpathy\\ is\\ seen\\ in\\ approximately\\ 0\\.1\\-2\\.5\\%\\ of\\ diabetic\\ patients\\,\\ but\\ it\\ is\\ largely\\ believed\\ that\\ the\\ occurrence\\ is\\ on\\ the\\ rise\\.\\ bilateral\\ disease\\ is\\ seen\\ in\\ approxametely\\ 10\\%\\ of\\ patients\\ with\\ a\\ recurrence\\ rate\\ of\\ less\\ than\\ 5\\%\\.\ \(0\)\
\-\ there\\ is\\ little\\ understanding\\ of\\ the\\ disease\\ process\\ of\\ charcot\\‚\\Ä\\ôs\\ arthopathy\\,\\ but\\ three\\ theories\\ have\\ been\\ hypothesized\\.\\ the\\ nuerotraumatic\\ theory\\ is\\ associated\\ with\\ exaggerated\\ overuse\\ injury\\ causing\\ microtrauma\\ or\\ a\\ single\\ traumatic\\ event\\ in\\ an\\ insensate\\ joint\\ that\\ leads\\ to\\ charcot\\ deformities\\.\\ the\\ neurovascular\\ theory\\ proposes\\ that\\ the\\ autonomic\\ dysfunction\\ causes\\ an\\ increase\\ in\\ arteriovenous\\ shunting\\ leading\\ to\\ increased\\ blood\\ flow\\.\\ thus\\,\\ amplifying\\ bone\\ resorption\\ and\\ weakening\\.\\ the\\ last\\ theory\\ involves\\ the\\ escalation\\ of\\ osteoclast\\ cells\\ due\\ to\\ the\\ action\\ of\\ inflammatory\\ cytokines\\.\\ the\\ literatures\\ now\\ suggest\\ that\\ charcot\\ arthorpathy\\ is\\ most\\ likely\\ due\\ from\\ a\\ combination\\ of\\ the\\ three\\ described\\ theories\\.\\ \ \(0\)\
\-\ the\\ clinical\\ presentation\\ of\\ charcot\\ arthropathy\\ can\\ vary\\ widely\\ depending\\ on\\ the\\ stage\\ of\\ the\\ disease\\.\\ acute\\ charoct\\ nueroarthropathy\\ of\\ the\\ foot\\ and\\ ankle\\ presents\\ with\\ one\\ or\\ more\\ of\\ the\\ following\\ symptoms\\:\\ swelling\\,\\ an\\ increase\\ in\\ local\\ skin\\ temperature\\ \\(3\\-7\\¬\\∞\\)\\,\\ erythema\\,\\ joint\\ effusion\\ and\\ an\\ insensate\\ foot\\.\\ the\\ majority\\ of\\ patients\\ will\\ have\\ mild\\ to\\ moderate\\ foot\\ pain\\ and\\ some\\ will\\ have\\ associated\\ foot\\ ulcers\\.\\ patients\\ may\\ report\\ to\\ clinic\\ following\\ a\\ traumatic\\ event\\,\\ but\\ most\\ patients\\ are\\ unable\\ to\\ identify\\ an\\ event\\ causing\\ foot\\ trauma\\.\\ on\\ physical\\ exam\\ the\\ patient\\ will\\ have\\ dependent\\ rubor\\,\\ bounding\\ pulses\\ and\\ passive\\ motion\\ of\\ the\\ foot\\/ankle\\ may\\ reveal\\ a\\ \\‚\\Ä\\úloose\\ bag\\ of\\ bones\\.\\‚\\Ä\\ù\\ the\\ acute\\ presentation\\ of\\ charcot\\ arthropathy\\ is\\ similar\\ to\\ the\\ clinical\\ presentation\\ of\\ osteomylitis\\ and\\ cellulitis\\.\\ these\\ conditions\\ must\\ be\\ ruled\\ out\\ by\\ the\\ clinical\\ physician\\ and\\ with\\ the\\ use\\ radiographic\\ imaging\\ and\\ labs\\.\\ \ \(0\)\
\-\ there\\ are\\ several\\ ways\\ to\\ stage\\ the\\ disease\\ process\\ of\\ charcot\\‚\\Ä\\ôs\\ arthropathy\\.\\ two\\ of\\ theses\\ classifications\\ will\\ be\\ discussed\\ here\\.\\ the\\ eichenholtz\\ classification\\ is\\ four\\ stages\\ that\\ combine\\ the\\ physical\\ exam\\ and\\ radiographic\\ findings\\ to\\ guide\\ treatment\\.\\ stage\\ 0\\ is\\ a\\ patient\\ presenting\\ with\\ acute\\ charcot\\ nueroarthropathy\\ as\\ described\\ above\\,\\ but\\ with\\ normal\\ radiographs\\.\\ stage\\ 1\\ is\\ the\\ fragmentation\\ or\\ dissolution\\ phase\\ in\\ which\\ there\\ will\\ be\\ similar\\ physical\\ exam\\ findings\\ as\\ in\\ stage\\ 0\\,\\ but\\ plain\\ radiographs\\ will\\ show\\ osteopenia\\,\\ periarticular\\ fragmentation\\ and\\ subluxation\\ or\\ dislocation\\ of\\ the\\ joints\\.\\ stage\\ 2\\ is\\ the\\ coalescence\\ phase\\ describing\\ the\\ early\\ healing\\ phase\\.\\ there\\ is\\ less\\ swelling\\,\\ but\\ plain\\ radiographs\\ demonstrate\\ absorption\\ of\\ debris\\,\\ fusion\\ of\\ bony\\ fragments\\ and\\ early\\ sclerosis\\.\\ stage\\ 3\\ is\\ the\\ reconstruction\\ phase\\ with\\ no\\ inflammation\\ and\\ stable\\ joints\\ on\\ physical\\ exam\\.\\ at\\ this\\ stage\\,\\ the\\ plain\\ radiographs\\ exhibit\\ joint\\ arthrosis\\,\\ osteophytes\\,\\ and\\ subchondral\\ sclerosis\\.\\ \ \(0\)\
\-\ the\\ bodsky\\ anatomic\\ classification\\ of\\ the\\ charcot\\ foot\\ stages\\ the\\ specific\\ pattern\\ of\\ collapse\\.\\ type\\ 1\\,\\ the\\ most\\ common\\,\\ involves\\ the\\ collapse\\ of\\ the\\ tarsometatarsal\\ joint\\.\\ this\\ deformity\\ can\\ cause\\ a\\ fixed\\ rocker\\-bottom\\ foot\\ with\\ valgus\\ angulation\\.\\ type\\ 2\\ collapse\\ affects\\ the\\ subtalar\\ and\\ chopart\\ joints\\.\\ type\\ 3\\ collapse\\ involves\\ the\\ ankle\\ joint\\.\\ this\\ type\\ of\\ collapse\\ is\\ more\\ likely\\ to\\ cause\\ recurrent\\ ulceration\\ and\\ osteomyelitis\\ over\\ the\\ malleoli\\.\ \(0\)\
\-\ traditionally\\,\\ serial\\ plain\\ radiographs\\ are\\ used\\ to\\ follow\\ the\\ progression\\ of\\ charcot\\ arthropathy\\.\\ futher\\ imaging\\ is\\ warranted\\ if\\ there\\ is\\ clinical\\ suspicion\\ for\\ osteomyelitis\\.\\ a\\ three\\ phase\\ tc\\-99m\\ methylene\\ diphosponate\\ scintigraphy\\,\\ followed\\ by\\ indium\\ in\\-111\\-labeled\\ leukocyte\\ scintigraphy\\,\\ has\\ been\\ found\\ to\\ have\\ a\\ sensitivity\\ of\\ 93\\%\\ to\\ 100\\%\\ and\\ a\\ specificity\\ of\\ approximately\\ 80\\%\\ for\\ osteomyelitis\\.\\ mri\\ has\\ been\\ found\\ to\\ be\\ less\\ specific\\ for\\ osteomyelitis\\.\\ \\ with\\ this\\ said\\,\\ mri\\ was\\ found\\ to\\ be\\ most\\ helpful\\ in\\ recognizing\\ charcot\\ arthropathy\\ during\\ stage\\ 0\\ when\\ there\\ are\\ normal\\ plain\\ radiographs\\.\\ mri\\ is\\ useful\\ in\\ identifying\\ bone\\ marrow\\ edema\\ and\\ stress\\ bone\\ injury\\ prior\\ to\\ any\\ abnormalities\\ can\\ be\\ seen\\ on\\ plain\\ radiographs\\.\\ \\ \ \(0\)\
\-\ the\\ management\\ and\\ treatment\\ of\\ charcot\\ arthopathy\\ varies\\ on\\ the\\ degree\\ of\\ progression\\ and\\ severity\\.\\ the\\ classification\\ systems\\,\\ like\\ the\\ ones\\ described\\ above\\,\\ provide\\ treatment\\ protocols\\ for\\ different\\ stages\\ of\\ the\\ disease\\ process\\ and\\ joint\\ locations\\.\\ it\\ is\\ important\\ to\\ recognize\\ that\\ every\\ patient\\ will\\ heal\\ differently\\,\\ so\\ the\\ clinical\\ physician\\ must\\ vary\\ treatment\\ protocols\\ as\\ needed\\.\\ conservative\\ management\\ is\\ the\\ primary\\ goal\\ in\\ the\\ management\\ of\\ charcot\\ arthopathy\\.\\ immobilization\\ is\\ the\\ mainstay\\ of\\ the\\ treatment\\.\\ a\\ total\\-contact\\ cast\\ is\\ the\\ most\\ widely\\ used\\ method\\ for\\ immobilization\\ with\\ frequent\\ cast\\ changes\\ to\\ reduce\\ complications\\.\\ following\\ removal\\ of\\ a\\ cast\\,\\ life\\ long\\ protection\\ of\\ the\\ foot\\ and\\ ankle\\ is\\ provided\\ by\\ specialized\\ foot\\ braces\\ and\\ shoes\\.\\ operative\\ management\\ is\\ avoided\\ in\\ most\\ cases\\,\\ but\\ is\\ used\\ in\\ approximately\\ 25\\%\\ of\\ cases\\.\\ there\\ is\\ only\\ a\\ little\\ amount\\ of\\ literature\\ to\\ support\\ the\\ different\\ types\\ of\\ surgery\\ to\\ correct\\ charcot\\ arthropathy\\.\\ a\\ surgeon\\ will\\ consider\\ internal\\ fixation\\,\\ external\\ fixation\\,\\ exostectomy\\ and\\/or\\ arthrodesis\\ with\\ the\\ hopes\\ of\\ preventing\\ infection\\,\\ recurrent\\ ulcerations\\,\\ instability\\ and\\ the\\ need\\ for\\ an\\ amputation\\.\\ other\\ methods\\ of\\ treatment\\ are\\ under\\ investigation\\.\\ those\\ include\\ pharmacologic\\ treatment\\ such\\ as\\ bisphosphonates\\ and\\ calitonin\\,\\ low\\-intensity\\ ultrasound\\ and\\ electrical\\ stimulation\\.\\ \ \(0\)\
\-\ the\\ prognosis\\ for\\ charcot\\ arthorpathy\\ is\\ more\\ favorable\\ for\\ those\\ with\\ immediate\\ diagnosis\\ and\\ treatment\\.\\ outcomes\\ are\\ more\\ encouraging\\ for\\ forefoot\\ arthropathies\\ than\\ those\\ of\\ the\\ midfoot\\,\\ hindfoot\\ or\\ ankle\\.\\ the\\ healing\\ process\\ is\\ prolonged\\ by\\ ulcers\\,\\ infection\\ and\\ the\\ need\\ for\\ operative\\ intervention\\.\\ a\\ patient\\ suffering\\ from\\ a\\ non\\-complicated\\ charcot\\ arthropathy\\,\\ in\\ general\\,\\ will\\ recover\\ in\\ 1\\-2\\ years\\ if\\ there\\ is\\ a\\ timely\\ diagnosis\\,\\ appropriate\\ immobilization\\ and\\ long\\-term\\ preventative\\ measures\\ are\\ undertaken\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ charcot\\:\\ 0\\.10715818872724428\ \(0\)\
\-\ foot\\:\\ 0\\.051745550662561056\ \(0\)\
\-\ arthropathy\\:\\ 0\\.025950113084917646\ \(0\)\
\-\ stage\\:\\ 0\\.02529322271422908\ \(0\)\
\-\ ankle\\:\\ 0\\.02510770267141556\ \(0\)\
\-\ joint\\:\\ 0\\.021306316538489446\ \(0\)\
\-\ arthopathy\\:\\ 0\\.020390559191904006\ \(0\)\
\-\ cast\\:\\ 0\\.01914175336259229\ \(0\)\
\-\ will\\:\\ 0\\.018551525956370298\ \(0\)\
\-\ joints\\:\\ 0\\.018089022261502247\ \(0\)\
\-\ collapse\\:\\ 0\\.01685762207970772\ \(0\)\
\-\ diabetes\\:\\ 0\\.016308985910932636\ \(0\)\
\-\ is\\:\\ 0\\.015607145737741034\ \(0\)\
\-\ ulcers\\:\\ 0\\.015516819707164954\ \(0\)\
\-\ phase\\:\\ 0\\.015496252422396904\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.015309681331950297\ \(0\)\
\-\ radiographs\\:\\ 0\\.014605933607104802\ \(0\)\
\-\ theory\\:\\ 0\\.014457754201630596\ \(0\)\
\-\ clinical\\:\\ 0\\.014190569468359313\ \(0\)\
\-\ most\\:\\ 0\\.013689681014304305\ \(0\)\
\-\ insensate\\:\\ 0\\.013593706127936003\ \(0\)\
\-\ arthorpathy\\:\\ 0\\.013593706127936003\ \(0\)\
\-\ nueroarthropathy\\:\\ 0\\.013593706127936003\ \(0\)\
\-\ type\\:\\ 0\\.013325940917564736\ \(0\)\
\-\ plain\\:\\ 0\\.01283853683587857\ \(0\)\
\-\ patients\\:\\ 0\\.011936023281081095\ \(0\)\
\-\ stages\\:\\ 0\\.011858070092180173\ \(0\)\
\-\ 0\\:\\ 0\\.011858070092180173\ \(0\)\
\-\ there\\:\\ 0\\.01176606528726281\ \(0\)\
\-\ deformity\\:\\ 0\\.011348403968901268\ \(0\)\
\-\ classification\\:\\ 0\\.01129612827581073\ \(0\)\
\-\ but\\:\\ 0\\.011241346498279337\ \(0\)\
\-\ subluxation\\:\\ 0\\.010998632413462018\ \(0\)\
\-\ event\\:\\ 0\\.010920217105037157\ \(0\)\
\-\ \\%\\:\\ 0\\.010758093472183542\ \(0\)\
\-\ treatment\\:\\ 0\\.01066841609622752\ \(0\)\
\-\ immobilization\\:\\ 0\\.010630710991805068\ \(0\)\
\-\ theories\\:\\ 0\\.010593073669870754\ \(0\)\
\-\ protocols\\:\\ 0\\.010593073669870754\ \(0\)\
\-\ healing\\:\\ 0\\.010197685065618146\ \(0\)\
\-\ process\\:\\ 0\\.010146693862250467\ \(0\)\
\-\ have\\:\\ 0\\.00998694413921021\ \(0\)\
\-\ management\\:\\ 0\\.009944584251212463\ \(0\)\
\-\ more\\:\\ 0\\.009886706134057824\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.009845901078047248\ \(0\)\
\-\ \\,\\:\\ 0\\.00980984817217618\ \(0\)\
\-\ fragmentation\\:\\ 0\\.009524226822438302\ \(0\)\
\-\ s\\:\\ 0\\.009447832178545055\ \(0\)\
\-\ involves\\:\\ 0\\.009185808799170178\ \(0\)\
\-\ those\\:\\ 0\\.008993673258618258\ \(0\)\
\-\ widely\\:\\ 0\\.008693083413444182\ \(0\)\
\-\ disease\\:\\ 0\\.008615189151677435\ \(0\)\
\-\ prior\\:\\ 0\\.008458414696231162\ \(0\)\
\-\ valgus\\:\\ 0\\.00845537997500585\ \(0\)\
\-\ described\\:\\ 0\\.008417969216791062\ \(0\)\
\-\ vary\\:\\ 0\\.008401268456407129\ \(0\)\
\-\ recurrent\\:\\ 0\\.00834086107430627\ \(0\)\
\-\ the\\:\\ 0\\.008314143567373023\ \(0\)\
\-\ neuropathy\\:\\ 0\\.008111288145685557\ \(0\)\
\-\ are\\:\\ 0\\.00808316488262638\ \(0\)\
\-\ diabetic\\:\\ 0\\.00786730355784455\ \(0\)\
\-\ decade\\:\\ 0\\.007758409853582477\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.007656701345036916\ \(0\)\
\-\ used\\:\\ 0\\.0075825385280214996\ \(0\)\
\-\ commonly\\:\\ 0\\.0074584381884093475\ \(0\)\
\-\ deformities\\:\\ 0\\.00744261276392016\ \(0\)\
\-\ little\\:\\ 0\\.007156717276901867\ \(0\)\
\-\ operative\\:\\ 0\\.007109985820471137\ \(0\)\
\-\ to\\:\\ 0\\.006914749635545652\ \(0\)\
\-\ that\\:\\ 0\\.006827975613996099\ \(0\)\
\-\ presentation\\:\\ 0\\.006808174173842134\ \(0\)\
\-\ cubometatarsal\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ arthroapathy\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ neuroarthoropahty\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ myelomenignocele\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ nueuropathy\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ nueroarthorpathy\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ 0\\.1\\-2\\.5\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ approxametely\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ nuerotraumatic\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ amplifying\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ escalation\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ literatures\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ charoct\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ 3\\-7\\¬\\∞\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ bounding\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ bones\\.\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ theses\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ eichenholtz\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ bodsky\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ diphosponate\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ in\\-111\\-labeled\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ total\\-contact\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ exostectomy\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ calitonin\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ non\\-complicated\\:\\ 0\\.006796853063968001\ \(0\)\
\-\ less\\:\\ 0\\.006693770249011601\ \(0\)\
\-\ fixation\\:\\ 0\\.006689563006150025\ \(0\)\
\-\ cause\\:\\ 0\\.006687577393720816\ \(0\)\
\-\ three\\:\\ 0\\.006662970458782368\ \(0\)\
\-\ frequent\\:\\ 0\\.0065878544976044635\ \(0\)\
\-\ swelling\\:\\ 0\\.0065847591302570525\ \(0\)\
\-\ need\\:\\ 0\\.0065715366728850534\ \(0\)\
\-\ progression\\:\\ 0\\.0065553897185792786\ \(0\)\
\-\ different\\:\\ 0\\.006523594364373054\ \(0\)\
\-\ physical\\:\\ 0\\.006465706305570511\ \(0\)\
\-\ a\\:\\ 0\\.006421430869846281\ \(0\)\
\-\ an\\:\\ 0\\.006377528180411032\ \(0\)\
\-\ calcaneocuboid\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ neuroarthropathy\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ tabes\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ 20\\-24\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ 5\\-9\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ proposes\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ rubor\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ osteomylitis\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ rocker\\-bottom\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ chopart\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ futher\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ differently\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ preventative\\:\\ 0\\.006262429640251775\ \(0\)\
\-\ noted\\:\\ 0\\.006246480149429742\ \(0\)\
\-\ found\\:\\ 0\\.006229049223867646\ \(0\)\
\-\ physician\\:\\ 0\\.006211297889258986\ \(0\)\
\-\ for\\:\\ 0\\.006183646596044616\ \(0\)\
\-\ imaging\\:\\ 0\\.0061744759428083345\ \(0\)\
\-\ in\\:\\ 0\\.00617312827499217\ \(0\)\
\-\ approximately\\:\\ 0\\.006115230130814764\ \(0\)\
\-\ be\\:\\ 0\\.006096021850473072\ \(0\)\
\-\ must\\:\\ 0\\.006006996913089241\ \(0\)\
\-\ so\\:\\ 0\\.005995782172412172\ \(0\)\
\-\ can\\:\\ 0\\.005977555443235373\ \(0\)\
\-\ leprosy\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ osteoclast\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ cytokines\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ foot\\/ankle\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ tarsometatarsal\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ low\\-intensity\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ encouraging\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ arthropathies\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ timely\\:\\ 0\\.00594981197787077\ \(0\)\
\-\ years\\:\\ 0\\.005803954827336505\ \(0\)\
\-\ exam\\:\\ 0\\.005789464733845916\ \(0\)\
\-\ bka\\:\\ 0\\.005728006216535549\ \(0\)\
\-\ countries\\:\\ 0\\.005728006216535549\ \(0\)\
\-\ combine\\:\\ 0\\.005728006216535549\ \(0\)\
\-\ dissolution\\:\\ 0\\.005728006216535549\ \(0\)\
\-\ coalescence\\:\\ 0\\.005728006216535549\ \(0\)\
\-\ specialized\\:\\ 0\\.005728006216535549\ \(0\)\
\-\ causing\\:\\ 0\\.005692450955378935\ \(0\)\
\-\ and\\:\\ 0\\.005690338654603667\ \(0\)\
\-\ following\\:\\ 0\\.005609740378337274\ \(0\)\
\-\ persons\\:\\ 0\\.005555960301875403\ \(0\)\
\-\ insensitivity\\:\\ 0\\.005555960301875403\ \(0\)\
\-\ hypothesized\\:\\ 0\\.005555960301875403\ \(0\)\
\-\ autonomic\\:\\ 0\\.005555960301875403\ \(0\)\
\-\ weakening\\:\\ 0\\.005555960301875403\ \(0\)\
\-\ malleoli\\:\\ 0\\.005555960301875403\ \(0\)\
\-\ methylene\\:\\ 0\\.005555960301875403\ \(0\)\
\-\ increase\\:\\ 0\\.005527231776579663\ \(0\)\
\-\ traumatic\\:\\ 0\\.005519007650172011\ \(0\)\
\-\ specific\\:\\ 0\\.005446900069743269\ \(0\)\
\-\ describing\\:\\ 0\\.005415388554154544\ \(0\)\
\-\ indium\\:\\ 0\\.005415388554154544\ \(0\)\
\-\ protection\\:\\ 0\\.005415388554154544\ \(0\)\
\-\ braces\\:\\ 0\\.005415388554154544\ \(0\)\
\-\ hindfoot\\:\\ 0\\.005415388554154544\ \(0\)\
\-\ been\\:\\ 0\\.00537732048449651\ \(0\)\
\-\ recognizing\\:\\ 0\\.005296536834935377\ \(0\)\
\-\ arthrodesis\\:\\ 0\\.005296536834935377\ \(0\)\
\-\ pharmacologic\\:\\ 0\\.005296536834935377\ \(0\)\
\-\ seen\\:\\ 0\\.005207795266207217\ \(0\)\
\-\ talonavicular\\:\\ 0\\.005193582792819323\ \(0\)\
\-\ noninfectious\\:\\ 0\\.005193582792819323\ \(0\)\
\-\ classifications\\:\\ 0\\.005193582792819323\ \(0\)\
\-\ arthrosis\\:\\ 0\\.005193582792819323\ \(0\)\
\-\ mainstay\\:\\ 0\\.005193582792819323\ \(0\)\
\-\ shoes\\:\\ 0\\.005193582792819323\ \(0\)\
\-\ similar\\:\\ 0\\.005168367955190267\ \(0\)\
\-\ causes\\:\\ 0\\.005129654121526309\ \(0\)\
\-\ talocalcaneal\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ freiberg\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ infraction\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ dorsalis\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ understanding\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ ways\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ ones\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ hopes\\:\\ 0\\.005102770891773537\ \(0\)\
\-\ hallux\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ overuse\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ microtrauma\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ traditionally\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ avoided\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ ulcerations\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ forefoot\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ midfoot\\:\\ 0\\.0050215368781591765\ \(0\)\
\-\ radiographic\\:\\ 0\\.00500133290946605\ \(0\)\
\-\ as\\:\\ 0\\.004982951063585689\ \(0\)\
\-\ planus\\:\\ 0\\.004948051774223691\ \(0\)\
\-\ action\\:\\ 0\\.004948051774223691\ \(0\)\
\-\ bisphosphonates\\:\\ 0\\.004948051774223691\ \(0\)\
\-\ studies\\:\\ 0\\.004921358392874571\ \(0\)\
\-\ bone\\:\\ 0\\.004911568268604171\ \(0\)\
\-\ pes\\:\\ 0\\.004880965130438317\ \(0\)\
\-\ exaggerated\\:\\ 0\\.004880965130438317\ \(0\)\
\-\ bag\\:\\ 0\\.004880965130438317\ \(0\)\
\-\ absorption\\:\\ 0\\.004880965130438317\ \(0\)\
\-\ subtalar\\:\\ 0\\.004880965130438317\ \(0\)\
\-\ suffering\\:\\ 0\\.004880965130438317\ \(0\)\
\-\ recover\\:\\ 0\\.004880965130438317\ \(0\)\
\-\ acute\\:\\ 0\\.004880214331009627\ \(0\)\
\-\ of\\:\\ 0\\.0048505822999933505\ \(0\)\
\-\ above\\:\\ 0\\.004829512192178591\ \(0\)\
\-\ congenital\\:\\ 0\\.004819057778939765\ \(0\)\
\-\ early\\:\\ 0\\.004819057778939765\ \(0\)\
\-\ uncontrolled\\:\\ 0\\.004762113411219151\ \(0\)\
\-\ neurovascular\\:\\ 0\\.004762113411219151\ \(0\)\
\-\ guide\\:\\ 0\\.004762113411219151\ \(0\)\
\-\ said\\:\\ 0\\.004762113411219151\ \(0\)\
\-\ electrical\\:\\ 0\\.004762113411219151\ \(0\)\
\-\ undertaken\\:\\ 0\\.004762113411219151\ \(0\)\
\-\ sclerosis\\:\\ 0\\.004732945618236461\ \(0\)\
\-\ visits\\:\\ 0\\.004708919215778171\ \(0\)\
\-\ alcoholism\\:\\ 0\\.004708919215778171\ \(0\)\
\-\ 93\\:\\ 0\\.004708919215778171\ \(0\)\
\-\ 1\\:\\ 0\\.004703145029976191\ \(0\)\
\-\ recognize\\:\\ 0\\.004568347468057312\ \(0\)\
\-\ mri\\:\\ 0\\.004541116086926646\ \(0\)\
\-\ leukocyte\\:\\ 0\\.004526661098535126\ \(0\)\
\-\ methods\\:\\ 0\\.004526661098535126\ \(0\)\
\-\ outcomes\\:\\ 0\\.004526661098535126\ \(0\)\
\-\ heal\\:\\ 0\\.00448711345444295\ \(0\)\
\-\ preventing\\:\\ 0\\.00448711345444295\ \(0\)\
\-\ periarticular\\:\\ 0\\.0044494957488381455\ \(0\)\
\-\ investigation\\:\\ 0\\.0044494957488381455\ \(0\)\
\-\ neuropathic\\:\\ 0\\.004413628350507465\ \(0\)\
\-\ cases\\:\\ 0\\.004389839420171369\ \(0\)\
\-\ by\\:\\ 0\\.00438819091208905\ \(0\)\
\-\ exhibit\\:\\ 0\\.004379355596019544\ \(0\)\
\-\ sixth\\:\\ 0\\.004346541706722091\ \(0\)\
\-\ today\\:\\ 0\\.004315067539782804\ \(0\)\
\-\ occurrence\\:\\ 0\\.004315067539782804\ \(0\)\
\-\ varies\\:\\ 0\\.004315067539782804\ \(0\)\
\-\ amputation\\:\\ 0\\.004315067539782804\ \(0\)\
\-\ largely\\:\\ 0\\.004284827976827305\ \(0\)\
\-\ specificity\\:\\ 0\\.004284827976827305\ \(0\)\
\-\ goal\\:\\ 0\\.004284827976827305\ \(0\)\
\-\ favorable\\:\\ 0\\.004284827976827305\ \(0\)\
\-\ 2\\:\\ 0\\.0042562170312503\ \(0\)\
\-\ rise\\:\\ 0\\.004255729805676306\ \(0\)\
\-\ several\\:\\ 0\\.004236072221622803\ \(0\)\
\-\ injury\\:\\ 0\\.004200784181786893\ \(0\)\
\-\ shunting\\:\\ 0\\.0042006342282035645\ \(0\)\
\-\ resorption\\:\\ 0\\.0042006342282035645\ \(0\)\
\-\ warranted\\:\\ 0\\.004174495792061945\ \(0\)\
\-\ any\\:\\ 0\\.004149321562177785\ \(0\)\
\-\ identifying\\:\\ 0\\.00412473594538687\ \(0\)\
\-\ method\\:\\ 0\\.004101010688126459\ \(0\)\
\-\ stimulation\\:\\ 0\\.004101010688126459\ \(0\)\
\-\ contact\\:\\ 0\\.004077993754317916\ \(0\)\
\-\ ulceration\\:\\ 0\\.004055644072842778\ \(0\)\
\-\ pain\\:\\ 0\\.004023161786934213\ \(0\)\
\-\ describes\\:\\ 0\\.004012799160618561\ \(0\)\
\-\ debris\\:\\ 0\\.004012799160618561\ \(0\)\
\-\ x\\-rays\\:\\ 0\\.0039922376748189\ \(0\)\
\-\ controlled\\:\\ 0\\.003952690030726724\ \(0\)\
\-\ destructive\\:\\ 0\\.003952690030726724\ \(0\)\
\-\ believed\\:\\ 0\\.003952690030726724\ \(0\)\
\-\ passive\\:\\ 0\\.003952690030726724\ \(0\)\
\-\ osteophytes\\:\\ 0\\.003952690030726724\ \(0\)\
\-\ identify\\:\\ 0\\.003933651778922275\ \(0\)\
\-\ cellulitis\\:\\ 0\\.003915072325121919\ \(0\)\
\-\ picture\\:\\ 0\\.0038618781296809396\ \(0\)\
\-\ correct\\:\\ 0\\.0038618781296809396\ \(0\)\
\-\ or\\:\\ 0\\.0038609203892201525\ \(0\)\
\-\ toe\\:\\ 0\\.0038449321723033176\ \(0\)\
\-\ average\\:\\ 0\\.0038449321723033176\ \(0\)\
\-\ locations\\:\\ 0\\.0038449321723033176\ \(0\)\
\-\ infection\\:\\ 0\\.0038304033524638502\ \(0\)\
\-\ loose\\:\\ 0\\.003828350672518458\ \(0\)\
\-\ osteopenia\\:\\ 0\\.003828350672518458\ \(0\)\
\-\ angulation\\:\\ 0\\.003828350672518458\ \(0\)\
\-\ reconstruction\\:\\ 0\\.0038121182830058655\ \(0\)\
\-\ fixed\\:\\ 0\\.0038121182830058655\ \(0\)\
\-\ affect\\:\\ 0\\.003796220605902753\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.003780644116066578\ \(0\)\
\-\ changes\\:\\ 0\\.00377648107360842\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.00376537609193691\ \(0\)\
\-\ affects\\:\\ 0\\.0037504045531110797\ \(0\)\
\-\ temperature\\:\\ 0\\.00372130638196008\ \(0\)\
\-\ sensitivity\\:\\ 0\\.00372130638196008\ \(0\)\
\-\ reduce\\:\\ 0\\.00372130638196008\ \(0\)\
\-\ likely\\:\\ 0\\.003716715444773564\ \(0\)\
\-\ this\\:\\ 0\\.0037052321253436124\ \(0\)\
\-\ include\\:\\ 0\\.0036964587325062246\ \(0\)\
\-\ provide\\:\\ 0\\.003693266563786699\ \(0\)\
\-\ leads\\:\\ 0\\.0036796200124378934\ \(0\)\
\-\ ruled\\:\\ 0\\.003666210804487339\ \(0\)\
\-\ long\\-term\\:\\ 0\\.003640072368345719\ \(0\)\
\-\ metatarsal\\:\\ 0\\.0036273281108659882\ \(0\)\
\-\ fifth\\:\\ 0\\.003614791086292526\ \(0\)\
\-\ trauma\\:\\ 0\\.0036037143897577934\ \(0\)\
\-\ discussed\\:\\ 0\\.003602454662740914\ \(0\)\
\-\ great\\:\\ 0\\.003590312521670644\ \(0\)\
\-\ severity\\:\\ 0\\.0035783586384509334\ \(0\)\
\-\ consider\\:\\ 0\\.0035783586384509334\ \(0\)\
\-\ if\\:\\ 0\\.0035755488570248808\ \(0\)\
\-\ at\\:\\ 0\\.003570587980976509\ \(0\)\
\-\ dependent\\:\\ 0\\.0035549929102355687\ \(0\)\
\-\ literature\\:\\ 0\\.0035435703306016895\ \(0\)\
\-\ support\\:\\ 0\\.0035323145099223118\ \(0\)\
\-\ due\\:\\ 0\\.00351623308088333\ \(0\)\
\-\ dysfunction\\:\\ 0\\.0035102841533733095\ \(0\)\
\-\ surgeon\\:\\ 0\\.0035102841533733095\ \(0\)\
\-\ systems\\:\\ 0\\.0034995006206248597\ \(0\)\
\-\ every\\:\\ 0\\.0034995006206248597\ \(0\)\
\-\ prolonged\\:\\ 0\\.0034995006206248597\ \(0\)\
\-\ duration\\:\\ 0\\.003488865831008564\ \(0\)\
\-\ 31\\:\\ 0\\.003457814251102673\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.003457814251102673\ \(0\)\
\-\ subchondral\\:\\ 0\\.003457814251102673\ \(0\)\
\-\ than\\:\\ 0\\.003452658218840823\ \(0\)\
\-\ common\\:\\ 0\\.0034483688696320693\ \(0\)\
\-\ fragments\\:\\ 0\\.003447735545191067\ \(0\)\
\-\ immediate\\:\\ 0\\.003447735545191067\ \(0\)\
\-\ here\\:\\ 0\\.0034377868907300743\ \(0\)\
\-\ useful\\:\\ 0\\.0034377868907300743\ \(0\)\
\-\ depending\\:\\ 0\\.003427964974170761\ \(0\)\
\-\ suspicion\\:\\ 0\\.003418266607010498\ \(0\)\
\-\ sensory\\:\\ 0\\.003408688719579074\ \(0\)\
\-\ pulses\\:\\ 0\\.003408688719579074\ \(0\)\
\-\ helpful\\:\\ 0\\.003408688719579074\ \(0\)\
\-\ instability\\:\\ 0\\.0033898826647416344\ \(0\)\
\-\ types\\:\\ 0\\.0033625066520531917\ \(0\)\
\-\ on\\:\\ 0\\.003348763357126113\ \(0\)\
\-\ anatomic\\:\\ 0\\.0033274547059647134\ \(0\)\
\-\ 100\\:\\ 0\\.0033274547059647134\ \(0\)\
\-\ combination\\:\\ 0\\.0033189351715109086\ \(0\)\
\-\ patient\\:\\ 0\\.0033022048223453663\ \(0\)\
\-\ serial\\:\\ 0\\.0032857683364425267\ \(0\)\
\-\ symptoms\\:\\ 0\\.003283974521045704\ \(0\)\
\-\ thus\\:\\ 0\\.0032776948592896393\ \(0\)\
\-\ conditions\\:\\ 0\\.0032776948592896393\ \(0\)\
\-\ metabolic\\:\\ 0\\.003253969602029228\ \(0\)\
\-\ erythema\\:\\ 0\\.0032385488875290966\ \(0\)\
\-\ majority\\:\\ 0\\.0032385488875290966\ \(0\)\
\-\ poorly\\:\\ 0\\.003215981129394854\ \(0\)\
\-\ leading\\:\\ 0\\.003151989672516698\ \(0\)\
\-\ periosteal\\:\\ 0\\.0031251692283490685\ \(0\)\
\-\ prognosis\\:\\ 0\\.0031251692283490685\ \(0\)\
\-\ associated\\:\\ 0\\.003109425692995685\ \(0\)\
\-\ appropriate\\:\\ 0\\.003105648944629493\ \(0\)\
\-\ dislocation\\:\\ 0\\.0030992504844793807\ \(0\)\
\-\ 80\\:\\ 0\\.0030992504844793807\ \(0\)\
\-\ degree\\:\\ 0\\.0030866106928250426\ \(0\)\
\-\ 3\\:\\ 0\\.0030855443742583495\ \(0\)\
\-\ like\\:\\ 0\\.0030498889896721864\ \(0\)\
\-\ unable\\:\\ 0\\.0030439352147347072\ \(0\)\
\-\ local\\:\\ 0\\.0030263448695025015\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003025781543223469\ \(0\)\
\-\ reaction\\:\\ 0\\.002992324202649041\ \(0\)\
\-\ present\\:\\ 0\\.002976112188021096\ \(0\)\
\-\ it\\:\\ 0\\.002961986714777204\ \(0\)\
\-\ important\\:\\ 0\\.0029597414661109663\ \(0\)\
\-\ report\\:\\ 0\\.0029491795198055217\ \(0\)\
\-\ clinic\\:\\ 0\\.0029439523131861087\ \(0\)\
\-\ fusion\\:\\ 0\\.0029387603068782102\ \(0\)\
\-\ reveal\\:\\ 0\\.0029336030299693464\ \(0\)\
\-\ intervention\\:\\ 0\\.0029336030299693464\ \(0\)\
\-\ from\\:\\ 0\\.0029293038854762044\ \(0\)\
\-\ marrow\\:\\ 0\\.002898436868633917\ \(0\)\
\-\ may\\:\\ 0\\.0028902519181158424\ \(0\)\
\-\ stress\\:\\ 0\\.0028886771177689024\ \(0\)\
\-\ under\\:\\ 0\\.00287903936698692\ \(0\)\
\-\ recurrence\\:\\ 0\\.002874265295862848\ \(0\)\
\-\ life\\:\\ 0\\.002874265295862848\ \(0\)\
\-\ needed\\:\\ 0\\.002869520603824006\ \(0\)\
\-\ four\\:\\ 0\\.002860117926033861\ \(0\)\
\-\ provided\\:\\ 0\\.002841649737119063\ \(0\)\
\-\ total\\:\\ 0\\.002837100992225317\ \(0\)\
\-\ measures\\:\\ 0\\.0028191697183901072\ \(0\)\
\-\ last\\:\\ 0\\.0028147513107501807\ \(0\)\
\-\ suggest\\:\\ 0\\.002805989738930354\ \(0\)\
\-\ findings\\:\\ 0\\.002804683015867324\ \(0\)\
\-\ inflammation\\:\\ 0\\.0028016460090010895\ \(0\)\
\-\ external\\:\\ 0\\.0028016460090010895\ \(0\)\
\-\ and\\/or\\:\\ 0\\.002784511747794682\ \(0\)\
\-\ bones\\:\\ 0\\.0027802870247687567\ \(0\)\
\-\ general\\:\\ 0\\.002776085324870865\ \(0\)\
\-\ amount\\:\\ 0\\.0027513449127263005\ \(0\)\
\-\ after\\:\\ 0\\.002726293296236241\ \(0\)\
\-\ stable\\:\\ 0\\.0027156619886214385\ \(0\)\
\-\ presents\\:\\ 0\\.0026918184973136867\ \(0\)\
\-\ where\\:\\ 0\\.0026890071358341688\ \(0\)\
\-\ presenting\\:\\ 0\\.0026852734238250802\ \(0\)\
\-\ single\\:\\ 0\\.0026705168006865318\ \(0\)\
\-\ 25\\:\\ 0\\.0026632430672760775\ \(0\)\
\-\ reports\\:\\ 0\\.0026560373136768197\ \(0\)\
\-\ motion\\:\\ 0\\.0026488982809761284\ \(0\)\
\-\ cells\\:\\ 0\\.0026418247449113315\ \(0\)\
\-\ bony\\:\\ 0\\.0026348155146096726\ \(0\)\
\-\ conservative\\:\\ 0\\.002631334650805103\ \(0\)\
\-\ complications\\:\\ 0\\.002610773165005441\ \(0\)\
\-\ progressive\\:\\ 0\\.002604039410210719\ \(0\)\
\-\ use\\:\\ 0\\.002604039410210719\ \(0\)\
\-\ removal\\:\\ 0\\.0025973639570548864\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0025940477798001523\ \(0\)\
\-\ moderate\\:\\ 0\\.0025907458046328423\ \(0\)\
\-\ rate\\:\\ 0\\.0025680196534123693\ \(0\)\
\-\ developed\\:\\ 0\\.002536673465562617\ \(0\)\
\-\ second\\:\\ 0\\.0025305543062752334\ \(0\)\
\-\ skin\\:\\ 0\\.0025305543062752334\ \(0\)\
\-\ pattern\\:\\ 0\\.0025184597834011398\ \(0\)\
\-\ effusion\\:\\ 0\\.0025036036393256754\ \(0\)\
\-\ has\\:\\ 0\\.002474479522735972\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.0024606791964372856\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.0024468861627049993\ \(0\)\
\-\ year\\-old\\:\\ 0\\.0024200189835761115\ \(0\)\
\-\ abnormalities\\:\\ 0\\.0024200189835761115\ \(0\)\
\-\ extremity\\:\\ 0\\.0024095288894698825\ \(0\)\
\-\ labs\\:\\ 0\\.002291421747829713\ \(0\)\
\-\ inflammatory\\:\\ 0\\.002284746294673881\ \(0\)\
\-\ long\\:\\ 0\\.0022715663152141274\ \(0\)\
\-\ 3\\.\\:\\ 0\\.002254336323932712\ \(0\)\
\-\ now\\:\\ 0\\.002252209398382149\ \(0\)\
\-\ 10\\:\\ 0\\.002220990152927456\ \(0\)\
\-\ available\\:\\ 0\\.0022148951802928273\ \(0\)\
\-\ followed\\:\\ 0\\.002208848011857187\ \(0\)\
\-\ internal\\:\\ 0\\.002208848011857187\ \(0\)\
\-\ flow\\:\\ 0\\.0021773738449178998\ \(0\)\
\-\ out\\:\\ 0\\.0021773738449178998\ \(0\)\
\-\ 2\\.\\:\\ 0\\.002095176670624717\ \(0\)\
\-\ follow\\:\\ 0\\.0020934460076688\ \(0\)\
\-\ right\\:\\ 0\\.0020855012546887046\ \(0\)\
\-\ normal\\:\\ 0\\.0020657092592121836\ \(0\)\
\-\ such\\:\\ 0\\.002059624356083926\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0020579716008462612\ \(0\)\
\-\ severe\\:\\ 0\\.002027224209765616\ \(0\)\
\-\ show\\:\\ 0\\.002022479517726774\ \(0\)\
\-\ during\\:\\ 0\\.0020161983422697055\ \(0\)\
\-\ some\\:\\ 0\\.0020007156930352808\ \(0\)\
\-\ her\\:\\ 0\\.0019810421422397344\ \(0\)\
\-\ only\\:\\ 0\\.0019810421422397344\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0019546049229038575\ \(0\)\
\-\ primary\\:\\ 0\\.0019517226390868899\ \(0\)\
\-\ \\.\\:\\ 0\\.0019433053684746225\ \(0\)\
\-\ 5\\:\\ 0\\.0019276487451381366\ \(0\)\
\-\ two\\:\\ 0\\.0018869169141218238\ \(0\)\
\-\ when\\:\\ 0\\.0018869169141218238\ \(0\)\
\-\ head\\:\\ 0\\.0018686209025242065\ \(0\)\
\-\ edema\\:\\ 0\\.0018634722354905864\ \(0\)\
\-\ she\\:\\ 0\\.001849488158407226\ \(0\)\
\-\ history\\:\\ 0\\.0018199144760325109\ \(0\)\
\-\ with\\:\\ 0\\.0018042278502681532\ \(0\)\
\-\ months\\:\\ 0\\.0017994921316037526\ \(0\)\
\-\ blood\\:\\ 0\\.0017983123149647644\ \(0\)\
\-\ one\\:\\ 0\\.001785452107409903\ \(0\)\
\-\ mild\\:\\ 0\\.001734967967564485\ \(0\)\
\-\ these\\:\\ 0\\.0017146065473846105\ \(0\)\
\-\ over\\:\\ 0\\.0016774422437470797\ \(0\)\
\-\ consistent\\:\\ 0\\.0016154959667164248\ \(0\)\
\-\ increased\\:\\ 0\\.001611784719968894\ \(0\)\
\-\ surgery\\:\\ 0\\.0015998450766077678\ \(0\)\
\-\ bilateral\\:\\ 0\\.001598934255446757\ \(0\)\
\-\ without\\:\\ 0\\.0015512823179322747\ \(0\)\
\-\ woman\\:\\ 0\\.0015218989572003902\ \(0\)\
\-\ other\\:\\ 0\\.0015186110629934067\ \(0\)\
\-\ demonstrate\\:\\ 0\\.001516154310973817\ \(0\)\
\-\ lower\\:\\ 0\\.0014817749185534793\ \(0\)\
\-\ multiple\\:\\ 0\\.0013876684683726051\ \(0\)\
\-\ no\\:\\ 0\\.0013268221290729406\ \(0\)\
\-\ also\\:\\ 0\\.001298858591881381\ \(0\)\
\-\ which\\:\\ 0\\.0012298724651060515\ \(0\)\
\-\ not\\:\\ 0\\.0009520575726614767\ \(0\)\
\-\ \\:\\:\\ 0\\.000871453212020559\ \(0\)\
\-\ was\\:\\ 0\\.0007619718752611309\ \(0\)\
\-\ left\\:\\ 0\\.0007371667457771123\ \(0\)\
\-\ \\(\\:\\ 0\\.0005569481312597229\ \(0\)\
\-\ \\)\\:\\ 0\\.0005501447125006207\ \(0\)\
